share_log

HC Wainwright & Co. Reiterates Buy on ITeos Therapeutics, Maintains $44 Price Target

HC Wainwright & Co. Reiterates Buy on ITeos Therapeutics, Maintains $44 Price Target

HC Wainwright & Co.重申買入iTeos Therapeutics,維持44美元的目標股價
Benzinga ·  03/07 07:27

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates ITeos Therapeutics (NASDAQ:ITOS) with a Buy and maintains $44 price target.

HC Wainwright & Co. 分析師Swayampakula Ramakanth重申了iTEOS Therapeutics(納斯達克股票代碼:ITOS)的買入並維持44美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論